VivoSim Labs, Inc.

Healthcare · Biotechnology · United States

Last price 0.1577 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.62M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models. The company also provides liver toxicology predictive screening and research services, as well as works on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies ...